You are here: Industry Insights > BioNTech

News List

BioNTech and Fosun Pharma Receive Authorization for Emergency Use in Hong Kong, S.A.R., China for COVID-19 Vaccine prnewswire
January 26, 2021
BioNTech SE and Shanghai Fosun Pharmaceutical (Group) Co., Ltd. announced that according to the Food and Health Bureau of the Hong Kong, S.A.R., China Special Administrative Region of the PRC, the COVID-19 vaccine COMIRNATY® (also known as BNT162b2, Chine
Australia approves Pfizer-BioNTech’s Covid-19 vaccine pharmaceutical-technology
January 26, 2021
Australia’s Therapeutic Goods Administration (TGA) has provisionally approved the Pfizer-BioNTech Covid-19 vaccine for use in people aged 16 years and above.
Pfizer, BioNTech announce agreement with COVAX for advance purchase of COVID-19 vaccine expresspharma
January 25, 2021
Pfizer and BioNTech announced an advance purchase agreement with COVAX for up to 40 million doses of the Pfizer-BioNTech COVID-19 vaccine. The doses will be delivered throughout 2021.
Pfizer, BioNTech Study Shows COVID-19 Vaccine Elicits Antibodies that Neutralize New U.K. Strain americanpharmaceuticalreview
January 22, 2021
Pfizer and BioNTech announced results from an in vitro study that provides additional data on the capability of sera from individuals immunized with the Pfizer-BioNTech COVID-19 vaccine BNT162b2 to neutralize the SARS-CoV-2 U.K. strain, also known ...
$30 bn sales forecast for Pfizer-BioNTech COVID-19 vaccine from 2020-2026: GlobalData expresspharma
January 12, 2021
The main challenge for BNT-162b2 is the ultra-cold storage requirement of -80°C. The vaccine is likely to suffer poor uptake in countries that have limited cold-chain logistics.
An in vitro study shows Pfizer-BioNTech COVID-19 vaccine elicits antibodies that neutralize SARS-CoV-2 with a mutation associated with rapid transmission worldpharmanews
January 11, 2021
Pfizer Inc. and BioNTech SE announced results from an in vitro study conducted by Pfizer and the University of Texas Medical Branch (UTMB) that shows the antibodies from people who have received the Pfizer-BioNTech COVID-19 vaccine effectively ...
Study suggests Pfizer/BioNTech vaccine effective against Covid-19 variants pharmaceutical-technology
January 11, 2021
New research suggests that Pfizer/BioNTech’s mRNA Covid-19 vaccine, BNT162b2, protects against two variants of SARS-CoV-2, the virus that causes Covid-19, that have emerged in the UK and South Africa.
Colombia grants emergency use approval for Pfizer-BioNTech Covid-19 vaccine pharmaceutical-technology
January 07, 2021
Colombia’s National Institute of Drug and Food Surveillance (INVIMA) has authorised emergency use of Pfizer and BioNTech’s Covid-19 vaccine.
COVID-19 vaccine key conversation driver for Pfizer among Twitter influencers during Q4 2020– GlobalData expresspharma
January 07, 2021
The Medicines & Healthcare Products Regulatory Agency (MHRA) in the UK and the US Food and Drug Administration (FDA) authorised Pfizer and BioNTech’s mRNA vaccine (BNT162b2) for emergency use against COVID-19 in December 2020.
Germany says does not intend to delay second COVID-19 vaccine shot expresspharma
January 07, 2021
Germany intends to stick to recommendations by BioNTech and Pfizer regarding the administration of a second dose of their COVID-19 vaccines rather than delaying it, Health Minister Jens Spahn said on Wednesday.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 20 21 Next page